CS
OCRX

Credit Suisse’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Credit Suisse’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,671
Closed -$119K – 4709
2014
Q4 		$119K Buy
+18,671
New +$109K ﹤0.01% 4404
2014
Q2 		– Sell
-23,234
Closed -$246K – 4900
2014
Q1 		$246K Buy
+23,234
New +$332K ﹤0.01% 4228

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Credit Suisse's OCRX Position: Q1 2015 in Review

Credit Suisse sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2015, closing a stake of 18,671 shares — an estimated $119K sold.

Credit Suisse first reported a position in OCRX in Q1 2014 and held it in 2 quarters. The position peaked at $246K in Q1 2014. 34 funds tracked by Wall St. Rank hold OCRX as of Q1 2015.

  • Credit Suisse reported no remaining Ocera Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Credit Suisse sold 18,671 Ocera Therapeutics, Inc. shares in Q1 2015, an estimated $119K.
  • Credit Suisse first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • Credit Suisse's Ocera Therapeutics, Inc. position peaked at $246K in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.